To protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in genomics and personalized medicine, the unique needs of health disparity populations, and differences in the treatment response and the treatment preferences of patients.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment not agreed to: Amendment SA 793 not agreed to in Senate by Yea-Nay Vote. 44 - 54. Record Vote Number: 127.
April 1, 2009
View full timeline
Senate amendment not agreed to: Amendment SA 793 not agreed to in Senate by Yea-Nay Vote. 44 - 54. Record Vote Number: 127.
April 1, 2009
Roll call votes on amendments in Senate: Amendment SA 793 not agreed to in Senate by Yea-Nay Vote. 44 - 54. Record Vote Number: 127.
April 1, 2009
Senate amendment proposed (on the floor): Amendment SA 793 proposed by Senator Kyl.(consideration: CR S4125-4128, S4150; text: CR S4125)
April 1, 2009
Amendment SA 793 proposed by Senator Kyl. (consideration: CR S4125-4128, S4150; text: CR S4125) To protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in genomics and personalized medicine, the unique needs of health disparity populations, and differences in the treatment response and the treatment preferences of patients.
April 1, 2009
Amendment SA 793 not agreed to in Senate by Yea-Nay Vote. 44 - 54. Record Vote Number: 127.
April 1, 2009
Senate amendment submitted
March 31, 2009
Votes
1 roll call on this amendment
Text
Submitted
SA 793. Mr. KYL submitted an amendment intended to be proposed by him to the concurrent resolution S. Con. Res. 13, setting forth the congressional budget for the United States Government for fiscal year 2010, revising the appropriate budgetary levels for fiscal year 2009, and setting forth the appropriate budgetary levels for fiscal years 2011 through 2014; which was ordered to lie on the table; as follows: On page 31, line 9, insert ``does not curb growth in health care spending by using data obtained from comparative effectiveness research to deny coverage of items or services under Federal health care programs, ensures that comparative effectiveness research accounts for advancements in genomics and personalized medicine, the unique needs of health disparity populations, and differences in the treatment response and the treatment preferences of patients, and'' after legislation. ______